Your browser doesn't support javascript.
loading
Comparing efficacy and safety of regorafenib versus pemetrexed in lung cancer: A preliminary clinical trial evaluating effect of inflammatory biomarkers on disease progression.
Yao, Yuanshan; Zhou, Yinjie; Hua, Qingwang.
  • Yao Y; Department of Thoracic Surgery, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
  • Zhou Y; Department of Thoracic Surgery, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
  • Hua Q; Department of Thoracic Surgery, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
Pak J Pharm Sci ; 32(3 Special): 1293-1299, 2019 May.
Article en En | MEDLINE | ID: mdl-31551206
Search on Google
Banco de datos: MEDLINE Asunto principal: Biomarcadores / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Child / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Biomarcadores / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Child / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article